GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Question] France — has anyone got a straight answer on EU — 27 comments in the full submission. View in context.
562
c/glp1eu·submitted 6 months ago by u/fabio_ibarra

[Question] France — has anyone got a straight answer on EU

Questionbranch of 10 comments

Slightly embarrassed to be asking this, but: France — has anyone got a straight answer on EU. Asked in my own language at a local pharmacy and got a clearer answer in five minutes than a fortnight of forum reading. On cross-border prescriptions, since the assumption behind half these threads is wrong. There are EU…

Read the full submission and all 27 comments →

This branch

10 comments, started 6 months ago
u/patient_labslip_log53 points·6 months ago

a shortage in one member state is not a shortage in all of them

replysharereportpermalink
[removed]39 points·6 months ago

[removed by moderator]

replysharereportpermalink
u/fabio_ibarraOP28 points·6 months ago

Are you comparing the same presentation, or different pack sizes?

replysharereportpermalink
u/cesar_oyelaran9 points·6 months ago

ask for the Beipackzettel or the local equivalent, it answers most questions

replysharereportpermalink
u/fabio_ibarraOP13 points·6 months ago

private pricing varies enormously between neighbouring countries

replysharereportpermalink
u/honest_syringe_maybe15 points·6 months ago·edited

pharmacy margins are regulated differently in each country

replysharereportpermalink
u/dario_stanescu11 points·6 months ago

private pricing varies enormously between neighbouring countries

Agreed — and normalising pack size before comparing prices is the fix for half these threads.

replysharereportpermalink
u/oskar_malinowski32 points·6 months ago

pack sizes differ, so per-month comparisons need care

replysharereportpermalink
u/marit_coelho27 points·6 months ago

EU-wide advice is almost always wrong somewhere

replysharereportpermalink
load more comments (1) →

← back to the whole thread

About c/glp1eu

European access, country by country: prescription routes, reimbursement reality, pharmacy stock, EMA notices and the fact that "EU rules" is usually a national question wearing a European hat.

32kmembers
62submissions
Apr 2024created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/glp1eu rules
  1. Tag your country in the title. Bare "EU" questions get a template reply.
  2. Pricing posts need the date and the currency.
  3. EMA and national agency claims need a citation.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.